PLEASANTON, Calif., Nov. 15, 2023 /PRNewswire/ -- Movano Health (Nasdaq: MOVE) ('Movano Health' or the 'Company'), a purpose-driven healthcare solutions company at the intersection of medtech and consumer devices and makers of the Evie Ring, today announced that it has priced a $3.6 million underwritten public offering of 4,235,304 shares of its common stock.

加利福尼亚州普莱森顿，2023年11月15日/PRNewswire/-Movano Health（纳斯达克股票代码：MOVE）（'Movano Health'或'公司'），这是一家位于medtech与消费者交汇处的目的驱动医疗解决方案公司Evie-Ring的设备和制造商今天宣布其定价为360万美元承保的公开发行4235304股普通股。

The public offering price, before the underwriters' discount and commissions, for each share of common stock is $0.85. All of the securities in the underwritten public offering were sold by the Company. The Company has granted the underwriter a 30-day option to purchase up to an additional 15% of shares of common stock sold in the offering at the public offering price, less the underwriting discount.

在承销商折扣和委托之前，普通股每股的公开发行价格为0.85美元。承保公开产品中的所有证券均由公司出售。本公司已授予承销商30天的选择权，以公开发行价格购买本次发行的普通股股份的额外15%，减少承销折扣。

The offering is expected to close on November 17, 2023..

该产品预计于2023年11月17日结束。。

The Company intends to use the net proceeds from the offering for general corporate purposes, which may include funding product development and commercialization activities.

本公司打算将该产品的净收益用于一般公司目的，其中可能包括资助产品开发和商业化活动。

The Benchmark Company, LLC acted as sole book-running manager for the offering. The Liquid Venture Partners group at The Benchmark Company, LLC was responsible for sourcing and executing the offering.

Benchmark Company，LLC担任该产品的唯一图书运行经理。Benchmark Company，LLC的Liquid Venture Partners group负责采购和执行该产品。

K&L Gates LLP represented the Company and Greenberg Traurig, LLP represented the underwriter in the transaction.

K＆L Gates LLP代表该公司，Greenberg Traurig，LLP代表承销商进行交易。

The common stock described above was offered by Movano Health pursuant to a shelf registration statement on Form S-3 (File No. 333-264116), including a base prospectus, previously filed with and subsequently declared effective by the Securities and Exchange Commission (the 'SEC'). A preliminary prospectus supplement relating to the offering has been filed with the SEC and is available on the SEC's website at http://www.sec.gov.

上述普通股由Movano Health根据S-3表格（文件号333-264116）上的货架注册声明（包括基本IPO）提供，该说明书先前已提交并随后由证券交易委员会宣布生效（The“SEC”）。有关该产品的初步IPO补充资料已向证券交易委员会提交，并可在证券交易委员会的网站上查阅http://www.sec.gov.

A final prospectus supplement describing the terms of the offering will be filed with the SEC. Copies of the final prospectus supplement, and accompanying base prospectus relating to this offering, may be obtained, when available, from The Benchmark Company, LLC, 150 East 58th Street, 17th floor, New York, NY 10155, by email at [email protected], or by calling +1 (212)-312-6700..

描述产品条款的最终IPO补充文件将与最终IPO补充文件的第二部分一起提交。如果可获得，可从Benchmark Company，LLC，150 East 58获得最终IPO补充文件的副本以及与此产品相关的基本IPO。纽约州纽约市17楼街17号，邮编10155，电子邮件地址[受电子邮件保护]，或致电+1（212）-312-6700。。

This press release shall not constitute an offer to sell or a solicitation of an offer to buy, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction..

本新闻稿不得构成出售或征求购买报价的报价，也不得在任何州或管辖区销售这些证券，在注册或资格认证之前，此类报价，征求或销售将是非法的根据任何此类州或管辖区的证券法。。

About Movano HealthFounded in 2018, Movano Inc. (Nasdaq: MOVE), dba Movano Health, is developing a suite of purpose-driven healthcare solutions to bring medical-grade, high-quality data to the forefront of consumer health devices. Featuring modern form factors, Movano Health's devices capture a comprehensive picture of a person's vital health information and uniquely translate the data into personalized and intelligent insights that empower consumers to live healthier and more balanced lives.

关于Movano Health成立于2018年，Movano Inc.（纳斯达克股票代码：MOVE），dba Movano Health，正在开发一套专门驱动的医疗保健解决方案，将医疗级，高质量的数据带到消费者健康设备的最前沿。Movano Health的设备具有现代形状因素，可以全面了解一个人的重要健康信息，并将数据独特地转化为个性化和智能的见解，使消费者能够过上更健康，更均衡的生活。

Movano Health's end-to-end solutions will soon enable consumers and their healthcare professionals to utilize daily medical-grade data as a tool to proactively monitor and manage health outcomes..

Movano Health的端到端解决方案将很快使消费者及其医疗保健专业人员能够利用日常医疗等级数据作为积极监测和管理健康结果的工具。。

Forward Looking StatementsThis press release contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995 regarding the expected closing of the public offering and the intended use of proceeds from the offering. The offering is subject to market and other conditions and there can be no assurance as to whether or when the offering may be completed.

前瞻性声明本新闻稿包含1995年“私人证券诉讼改革法”含义内的前瞻性声明，涉及预期公开发行的结束以及发行收益的预期用途。该产品受市场和其他条件的约束，无法保证是否或何时可以完成该产品。

Forward-looking statements involve known and unknown risks, uncertainties and other factors that could cause actual results to differ materially, including those risks disclosed in the section 'Risk Factors' included in the preliminary prospectus supplement for the offering. Movano Health cautions readers not to place undue reliance on any forward-looking statements.

前瞻性陈述涉及可能导致实际结果出现重大差异的已知和未知风险，不确定性和其他因素，包括本产品初步IPO补充中包含的“风险因素”部分披露的风险。Movano Health警告读者不要过分依赖任何前瞻性陈述。

Any forward-looking statement in this release speaks only as of the date of this release. We undertake no obligation to publicly update any forward-looking statement, whether written or oral, that may be made from time to time, whether as a result of new information, future developments or otherwise..

本版本中的任何前瞻性声明仅在本版本发布之日起提及。我们不承担任何义务不时公开更新任何前瞻性声明，无论是书面还是口头声明，无论是由于新信息，未来发展还是其他原因。。

SOURCE Movano

来源Movano